(ASLN) Aslan Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Aslan Pharmaceuticals | (ASLN) share price targets
Complete technical analysis of Aslan Pharmaceuticals (ASLN) by charts plus indicators, forecast predictions and share price targets for Aslan Pharmaceuticals (ASLN)
Aslan Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-07-15 View latest technical analysis
10 day averaged volume of Aslan Pharmaceuticals is 58820
Date | Daily Closing Price | Open | High | Low | Volume |
15 Mon Jul 2024 | 1.38 | 1.31 | 1.65 | 1.31 | 19.685 times |
12 Fri Jul 2024 | 2.55 | 2.46 | 2.73 | 2.46 | 0.384 times |
11 Thu Jul 2024 | 2.47 | 2.26 | 2.50 | 2.17 | 0.349 times |
10 Wed Jul 2024 | 2.29 | 2.22 | 2.29 | 2.03 | 0.248 times |
09 Tue Jul 2024 | 2.20 | 2.06 | 2.26 | 2.06 | 0.219 times |
08 Mon Jul 2024 | 2.08 | 2.01 | 2.21 | 1.92 | 0.709 times |
05 Fri Jul 2024 | 1.93 | 2.23 | 2.37 | 1.82 | 1.056 times |
03 Wed Jul 2024 | 2.38 | 2.20 | 2.53 | 2.20 | 0.966 times |
03 Wed Jul 2024 | 2.38 | 2.20 | 2.53 | 2.20 | 0.966 times |
02 Tue Jul 2024 | 0.28 | 0.30 | 0.31 | 0.28 | 3.538 times |
Stock of Aslan Pharmaceuticals (ASLN) has showed a significant fall. This could be a good time to exit from this stock.
My analysis of stock is bullish for shortterm, and stock might move up till 2.1 or till 3.3. Use a stoploss of 1.15 and if this stock hits its stoploss, then it can fall down till 0.19
Share price targets for Aslan Pharmaceuticals (ASLN)
Target Type | Value |
Downside Target | 0.27 |
Downside Target | 0.28 |
Downside Target | 0.34 |
Downside Target | 0.39 |
Downside Target | 0.41 |
Downside Target | 0.50 |
Downside Target | 0.54 |
Downside Target | 0.62 |
Downside Target | 1.31 |
Upside Target | 1.65 |
Upside Target | 1.82 |
Upside Target | 1.92 |
Upside Target | 2.09 |
Upside Target | 2.53 |
Upside Target | 2.73 |
Intraday share price targets for Aslan Pharmaceuticals (ASLN)
Target Type | Value |
Downside Intraday Target | 1.24 |
Downside Intraday Target | 1.11 |
Upside Intraday Target | 1.58 |
Upside Intraday Target | 1.79 |
Upside Intraday Target | 1.45 |
Weekly technical analysis of Aslan Pharmaceuticals (ASLN)
Date | Weekly Closing Price | Open | High | Low | Volume |
15 Mon Jul 2024 | 1.38 | 1.31 | 1.65 | 1.31 | 10.311 times |
12 Fri Jul 2024 | 2.55 | 2.01 | 2.73 | 1.92 | 0.944 times |
05 Fri Jul 2024 | 1.93 | 2.20 | 2.53 | 1.82 | 0.333 times |
03 Wed Jul 2024 | 2.38 | 0.31 | 2.53 | 0.28 | 0.461 times |
28 Fri Jun 2024 | 0.30 | 0.34 | 0.34 | 0.27 | 1.12 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Aslan Pharmaceuticals (ASLN)
Date | Monthly Closing Price | Open | High | Low | Volume |
15 Mon Jul 2024 | 1.38 | 0.31 | 2.73 | 0.28 | 0.458 times |
28 Fri Jun 2024 | 0.30 | 0.45 | 0.50 | 0.27 | 0.832 times |
31 Fri May 2024 | 0.43 | 0.47 | 0.54 | 0.39 | 0.245 times |
30 Tue Apr 2024 | 0.46 | 0.61 | 0.62 | 0.41 | 0.348 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Aslan Pharmaceuticals (ASLN)
Price action analysis of Aslan Pharmaceuticals ( (ASLN) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Aslan Pharmaceuticals ( (ASLN) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Aslan Pharmaceuticals ( (ASLN) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Aslan Pharmaceuticals ( (ASLN) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Aslan Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Aslan Pharmaceuticals in short term and the buy signal is strong.
Aslan Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Aslan Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Aslan Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.39 and Aslan Pharmaceuticals (ASLN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Aslan Pharmaceuticals (ASLN) stock. Volume based technical analysis of Aslan Pharmaceuticals (ASLN) stock is negative.
Aslan Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Aslan Pharmaceuticals ( (ASLN) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Aslan Pharmaceuticals ( (ASLN) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Aslan Pharmaceuticals ( (ASLN) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Aslan Pharmaceuticals ( (ASLN) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Aslan Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Aslan Pharmaceuticals in short term and the buy signal is strong.
Aslan Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Aslan Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Aslan Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.39 and Aslan Pharmaceuticals (ASLN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Aslan Pharmaceuticals (ASLN) stock. Volume based technical analysis of Aslan Pharmaceuticals (ASLN) stock is negative.
Aslan Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.